Innovating Works

GIN

Desconocido
SensApp: Super sensitive detection of Alzheimer s disease biomarkers in plasma by an innovative droplet split... GINOLIS OY participó en un H2020: H2020-FETOPEN-2018-2020 The detection of biomarkers in body fluids is of great importance for disease early diagnosis. The clinical practice uses typically immunoas...
2018-12-17 - 2022-06-30 | Financiado
ULTRAPLACAD: ULTRAsensitive PLAsmonic devices for early CAncer Diagnosis GINOLIS OY participó en un H2020: H2020-PHC-2014-2015 Cancer biomarkers circulating in body fluids have been shown to reflect the pathological process and for this reason can be used for cancer...
2015-04-21 - 2018-10-31 | Financiado
ML²: Design platform for economic production of multilayer Micro Nano Bio Systems GINOLIS OY participó en un FP7: Microfluidics and lab-on-chip is an enabling technology with great growth potential. The life science industry has come to realise the trend...
Financiado
DIAGMAL: Translation of the direct on blood PCR NALFIA system into an innovative near point of care diagnosti... GINOLIS OY participó en un FP7: Accurate diagnosis of malaria is essential to timely install proper treatment. Current diagnostic methods for malaria have limitations, such...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.